It Introduced Ozempic to the World. Now It Must Remake Itself.
Lars Fruergaard Jorgensen has a problem: Too many people want what he’s selling. Mr. Jorgensen is the chief executive of Novo Nordisk, the Danish drugmaker. Even if the...
Read moreLars Fruergaard Jorgensen has a problem: Too many people want what he’s selling. Mr. Jorgensen is the chief executive of Novo Nordisk, the Danish drugmaker. Even if the...
Read more(Bloomberg) — Microsoft Corp.’s $13 billion investment into OpenAI Inc. is set to avoid a formal investigation by European Union...
White House Press Secretary Karine Jean-Pierre refused to comment on the Biden administration’s response, particularly a lack thereof, escalating tensions...
Twenty-three top Chinese swimmers tested positive for the same powerful banned substance seven months before the Tokyo Olympic Games in...
WASHINGTON — The Senate voted to reauthorize a powerful surveillance tool the U.S. government describes as critical to combating terrorism,...
The Senate early on Saturday approved an extension of a warrantless surveillance law, moving to renew it shortly after it...
(Bloomberg) — Zuora Inc. is exploring options including a potential sale, people with knowledge of the matter said. The California-based...
Workers at German car giant ‘s Chattanooga factory in Tennessee have voted to join the United Auto Workers , in...
A Michigan elementary school district is doubling down on a lesson for students about using novel gender pronouns, including the phrase “tree,” with...
Actress Susan Sarandon joined anti-Israel protesters assembled outside of Columbia University a day after more than a hundred pro-Palestinian activists...
(Bloomberg) — Federal jurors in New York heard sharply contrasting arguments on whether a trader manipulated the Mango Markets cryptocurrency...